康辰药业
(603590)
| 流通市值：49.16亿 | | | 总市值：49.40亿 |
| 流通股本：1.58亿 | | | 总股本：1.59亿 |
| 利润表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 营业总收入 | 462,795,750.69 | 214,870,397.3 | 915,123,690.39 | 692,220,405.14 |
| 营业总成本 | 354,733,995.85 | 156,475,838.57 | 724,859,248.04 | 534,795,468.49 |
| 其他经营收益 | | | | |
| 营业利润 | 126,038,331.53 | 60,552,430.3 | 203,016,640.4 | 161,262,569.23 |
| 利润总额 | 120,938,801.56 | 58,702,330.35 | 189,686,430.81 | 148,211,291.92 |
| 净利润 | 100,564,729.4 | 48,512,063.09 | 169,423,424.87 | 134,302,584.99 |
| 每股收益 | | | | |
| 其他综合收益 | -23,579,061.36 | 4,785,418.36 | -10,653,418.31 | -48,898,274.85 |
| 综合收益总额 | 76,985,668.04 | 53,297,481.45 | 158,770,006.56 | 85,404,310.14 |
| 资产负债表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 流动资产: | | | | |
| 流动资产合计 | 1,389,783,262.73 | 1,322,653,489.81 | 1,395,528,838.13 | 1,351,700,571.17 |
| 非流动资产: | | | | |
| 非流动资产合计 | 2,730,786,937.12 | 2,754,522,521.09 | 2,699,466,329.56 | 2,696,856,164.3 |
| 资产总计 | 4,120,570,199.85 | 4,077,176,010.9 | 4,094,995,167.69 | 4,048,556,735.47 |
| 流动负债: | | | | |
| 流动负债合计 | 544,897,320.26 | 433,812,505.06 | 459,447,457.05 | 433,030,825.67 |
| 非流动负债: | | | | |
| 非流动负债合计 | 101,025,064.53 | 135,597,066.34 | 139,063,293.77 | 130,399,732.97 |
| 负债合计 | 645,922,384.79 | 569,409,571.4 | 598,510,750.82 | 563,430,558.64 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 3,184,597,536.71 | 3,221,259,791.28 | 3,211,276,257.44 | 3,196,951,992.49 |
| 股东权益合计 | 3,474,647,815.06 | 3,507,766,439.5 | 3,496,484,416.87 | 3,485,126,176.83 |
| 负债和股东权益合计 | 4,120,570,199.85 | 4,077,176,010.9 | 4,094,995,167.69 | 4,048,556,735.47 |
| 现金流量表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 485,408,142.4 | 244,911,400.88 | 992,029,766.77 | 706,019,570.76 |
| 经营活动现金流出小计 | 480,849,472.39 | 224,314,436.42 | 876,351,418.68 | 622,120,320.66 |
| 经营活动产生的现金流量净额 | 4,558,670.01 | 20,596,964.46 | 115,678,348.09 | 83,899,250.1 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 624,110,260.87 | 517,833,367.2 | 1,213,447,484.34 | 1,014,041,071.43 |
| 投资活动现金流出小计 | 638,125,548.03 | 478,961,190.4 | 1,169,155,297.35 | 945,353,149.48 |
| 投资活动产生的现金流量净额 | -14,015,287.16 | 38,872,176.8 | 44,292,186.99 | 68,687,921.95 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 122,694,915 | 43,974,915 | 298,867,756.47 | 256,505,696.47 |
| 筹资活动现金流出小计 | 129,428,389.9 | 78,570,025.44 | 316,216,372.88 | 291,205,997.07 |
| 筹资活动产生的现金流量净额 | -6,733,474.9 | -34,595,110.44 | -17,348,616.41 | -34,700,300.6 |
| 汇率变动对现金及现金等价物的影响 | -136,993.57 | -84,904.01 | -26,524.81 | -1,701.25 |
| 现金及现金等价物净增加额 | -16,327,085.62 | 24,789,126.81 | 142,595,393.86 | 117,885,170.2 |
| 期末现金及现金等价物余额 | 316,246,010.08 | 357,362,222.51 | 332,573,095.7 | 307,862,872.04 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | -16,327,085.62 | - | 142,595,393.86 | - |
最新报告期：2026-05-28| 研究机构 | 分析师 | 预测每股收益(元) | 更新日 |
| 2026年 | 2027年 | 2028年 |
| 山西证券 | 魏赟,张智勇,邓周宇 | 1.17 | 1.33 | 1.58 | 2026-05-28 |